STRATA Skin Sciences Statistics
Share Statistics
STRATA Skin Sciences has 4.17M shares outstanding. The number of shares has increased by -88.1% in one year.
| Shares Outstanding | 4.17M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 18.97% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.46M |
| Failed to Deliver (FTD) Shares | 2.11K |
| FTD / Avg. Volume | 18.75% |
Short Selling Information
The latest short interest is 5.52K, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 5.52K |
| Short % of Shares Out | 0.13% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.44 |
Valuation Ratios
The PE ratio is -1.77 and the forward PE ratio is -2.69.
| PE Ratio | -1.77 |
| Forward PE | -2.69 |
| PS Ratio | 0.58 |
| Forward PS | 0.4 |
| PB Ratio | 1.51 |
| P/FCF Ratio | -3.47 |
| PEG Ratio | n/a |
Enterprise Valuation
STRATA Skin Sciences Inc. has an Enterprise Value (EV) of 26.72M.
| EV / Earnings | -2.47 |
| EV / Sales | 0.8 |
| EV / EBITDA | -7.91 |
| EV / EBIT | -3.11 |
| EV / FCF | -4.83 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 1.21.
| Current Ratio | 1.28 |
| Quick Ratio | 1.06 |
| Debt / Equity | 1.21 |
| Total Debt / Capitalization | 54.82 |
| Cash Flow / Debt | -0.03 |
| Interest Coverage | -5.25 |
Financial Efficiency
Return on equity (ROE) is -0.85% and return on capital (ROIC) is -30.12%.
| Return on Equity (ROE) | -0.85% |
| Return on Assets (ROA) | -0.26% |
| Return on Capital (ROIC) | -30.12% |
| Revenue Per Employee | 336.95K |
| Profits Per Employee | -109.39K |
| Employee Count | 99 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 5.57 |
Taxes
| Income Tax | -92.00K |
| Effective Tax Rate | 0.01 |
Stock Price Statistics
The stock price has increased by -50.66% in the last 52 weeks. The beta is 1.32, so STRATA Skin Sciences 's price volatility has been higher than the market average.
| Beta | 1.32 |
| 52-Week Price Change | -50.66% |
| 50-Day Moving Average | 3 |
| 200-Day Moving Average | 3.58 |
| Relative Strength Index (RSI) | 52.61 |
| Average Volume (20 Days) | 11.24K |
Income Statement
In the last 12 months, STRATA Skin Sciences had revenue of $33.36M and earned -$10.83M in profits. Earnings per share was $-3.1.
| Revenue | 33.36M |
| Gross Profit | 18.46M |
| Operating Income | -8.60M |
| Net Income | -10.83M |
| EBITDA | -3.38M |
| EBIT | -8.60M |
| Earnings Per Share (EPS) | -3.1 |
Balance Sheet
The company has $6.78M in cash and $15.63M in debt, giving a net cash position of -$8.85M.
| Cash & Cash Equivalents | 6.78M |
| Total Debt | 15.63M |
| Net Cash | -8.85M |
| Retained Earnings | -238.06M |
| Total Assets | 40.20M |
| Working Capital | 1.83M |
Cash Flow
In the last 12 months, operating cash flow was -$519.00K and capital expenditures -$5.02M, giving a free cash flow of -$5.54M.
| Operating Cash Flow | -519.00K |
| Capital Expenditures | -5.02M |
| Free Cash Flow | -5.54M |
| FCF Per Share | -1.59 |
Margins
Gross margin is 55.34%, with operating and profit margins of -25.79% and -32.47%.
| Gross Margin | 55.34% |
| Operating Margin | -25.79% |
| Pretax Margin | -32.74% |
| Profit Margin | -32.47% |
| EBITDA Margin | -10.13% |
| EBIT Margin | -25.79% |
| FCF Margin | -16.6% |
Dividends & Yields
SSKN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -103.33% |
| FCF Yield | -44.33% |
Analyst Forecast
Currently there are no analyst rating for SSKN.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jun 7, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Jun 7, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -7.97 |
| Piotroski F-Score | 4 |